Literature DB >> 2552846

mu-Opioid peptide modulation of cardiovascular and sympathoadrenal responses to stress.

L Marson1, J A Kiritsy-Roy, G R Van Loon.   

Abstract

The effects of mu- and delta-opioid receptor activation on sympathoadrenal and cardiovascular responses to stress were examined in conscious rats. The mu-selective agonist [D-Ala2,N-Me-Phe4,Gly5-ol]enkephalin (DAGO) or the delta-selective agonist [D-Pen2,D-Pen5]enkephalin (DPDPE) was injected into a lateral cerebral ventricle, then rats were stressed by restraint. Plasma catecholamines were measured, and arterial blood pressure and heart rate were recorded continuously. Restraint stress evoked increases in plasma catecholamines and heart rate in saline-pretreated rats. Both DAGO and DPDPE increased basal plasma levels of catecholamines and blood pressure, and DAGO, 5 nmol, produced bradycardia. DAGO, 5 nmol, but not DPDPE, potentiated the plasma catecholamine responses to restraint. However, the presence of DAGO or DPDPE during restraint resulted in decreases in heart rate and blood pressure. The effects of DAGO and DPDPE on plasma catecholamines, heart rate, and blood pressure were blocked by a mu-selective dose of naloxone but were not reversed by the delta-selective antagonist ICI 174864. These results indicate that mu-receptor stimulation during restraint stress facilitates sympathoadrenal and parasympathetic outflow and results in vasodilatation of some peripheral vascular beds.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552846     DOI: 10.1152/ajpregu.1989.257.4.R901

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Load dependence of changes in forearm and peripheral vascular resistance after acute leg exercise in man.

Authors:  M Piepoli; J E Isea; G Pannarale; S Adamopoulos; P Sleight; A J Coats
Journal:  J Physiol       Date:  1994-07-15       Impact factor: 5.182

2.  Effects of dorsal root entry zone lesions on CSF and plasma neuropeptides and catecholamines.

Authors:  N Fujiwara; K Shimoji; Y Kumagai; H Endoh; S Fukuda
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

3.  Regional haemodynamic effects of mu-, delta-, and kappa-opioid agonists microinjected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats.

Authors:  H Bachelard; M Pître
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

4.  High-dose remifentanil increases blood pressure and heart rate mediated by sympatho-activation in conscious rats.

Authors:  Tetsuro Shirasaka; Takeshi Yano; Takato Kunitake; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2012-11-07       Impact factor: 2.078

5.  Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis.

Authors:  A Jaferi; V M Pickel
Journal:  Neuroscience       Date:  2009-01-08       Impact factor: 3.590

Review 6.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

7.  Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems.

Authors:  Susanne Becker; Petra Schweinhardt
Journal:  Pain Res Treat       Date:  2011-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.